top of page

Helping MedTech CDMOs grow in Europe

Strategic positioning, market entry and commercial execution for MedTech CDMOs and suppliers.

Services

For international CDMOs and suppliers seeking to enter or expand within the European MedTech market.
  • European market and competitor mapping

  • Target segment prioritisation

  • Positioning and value proposition

  • Market entry strategy

  • Access to relevant OEMs and ecosystem partners

Services

Key Questions When Entering or Scaling in European MedTech

Why doesn’t success in the US or Asia automatically translate to Europe?

Europe is not one homogeneous market. Its MedTech supplier and CDMO landscape is fragmented across countries, technologies and regulatory roles. OEM relationships are often long-established, and outsourcing models differ by segment and region.

Success therefore requires more than transferring an existing sales approach. It requires a clear European positioning, focused target segments and an understanding of how local OEMs make sourcing decisions.

Are ISO 13485 certification and a European manufacturing site required?

ISO 13485 is often expected for critical, design-related or regulated programs, but certification alone is not a differentiator.

OEMs also evaluate application understanding, risk management, regulatory readiness and execution reliability. A European manufacturing site can strengthen credibility and customer access, but it is not always required for initial market entry.

Where do we fit in the value chain?

The European ecosystem ranges from specialized component suppliers and contract manufacturers to integrated CDMOs. Understanding your actual position in this value chain determines which customers, programs and entry routes are realistic. In some cases, the right route leads directly to an OEM; in others, an established CDMO or another ecosystem partner may be the more effective entry point.

Who are we really competing against?

Competition is not limited to companies with similar technologies or business models. Depending on the program, an EMS provider may compete with a plastics specialist, precision manufacturer or integrated CDMO.

Many European competitors are highly specialized, technically strong and deeply embedded in OEM relationships—even if they have limited international visibility.

Why should Europe be a strategic priority?

Germany, Switzerland, Ireland, the Nordics and Northern Italy are important clusters for MedTech headquarters, R&D and sourcing decisions. At the same time, manufacturing footprints often extend into Eastern Europe and other cost-competitive regions. Because many European OEMs operate globally, entering Europe can create opportunities that extend beyond the region itself.

About Me

20+ years in MedTech

Daniel Bakosch Profilbild

With global experience on both the OEM and CDMO sides, I understand the requirements of MedTech OEMs and manufacturing partners operating in regulated environments; from components and manufacturing processes to clinical applications.

  • Experience across MedTech OEMs, CDMOs and component suppliers

  • Clinical and emergency medical services background

  • Strong track record in business development and commercial strategy

  • Regulatory understanding of ISO 13485, MDR, FDA requirements and ISO 14971

  • Global network and international project experience

The European MedTech manufacturing landscape includes Electronic manufacturing service (EMS) providers, plastics specialists, precision manufacturers and integrated CDMOs - often competing for the same programs from different positions in the value chain. This creates blurred boundaries between component suppliers, contract manufacturers and strategic CDMO partners.

As a result, many companies misjudge both their competitive position and the markets in which they can realistically win.

Where would you place your company on this map?

1774006014074.jpeg

Source: Alira Health analysis, Global MedTech Contract Manufacturing Report (2024/2025)

Collaboration

Dark-Background

European MedTech Entry

Clarification whether a move into European MedTech, and Life Science ecosystem is strategically viable and how to approach it.

Dark-Background

Professional Assessment

Analysing your current status: product portfolio, target customers, commercial & sales readiness, regulatory base, technical differentiators, and internal alignment.

Dark-Background

Enablement

Support through the implementation phase from assessment and strategic targeting to concrete market actions.

Let´s map where your position in the medtech valiue chain

Hamburg, Germany

The execution can be managed either on-site or remotely within the EU

Don't hesitate to call me

  • LinkedIn

Thank you for submitting!

Only the information you send us to contact you in connection with your inquiry will be used, if you request me to do so. For further information, please refer to the privacy policy.

bottom of page